Author:Qingfeng Pharmaceutical Group
Posted Time:2021-02-03 00:00
On February 3, Shanghai Yangguang Pharmaceutical Purchasing Network officially released the bidding results of fourth batch of national volume based procurement. Jiangxi Shanxiang Pharmaceutical Co., Ltd. (a subsidiary of Qingfeng Pharmaceutical Group) stood out for two products and successfully won the bid, namely Bangkaxin® Es omeprazole magnesium enteric-coated Tablets, and Ligesitai® Sorafenib tosylate tablets.
┃ Bangkaxin® Es omeprazole magnesium enteric-coated Tablets
┃ Ligesitai® Sorafenib tosylate tablets
